These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4723777)

  • 1. The purification and properties of factor X from pig serum and its role in hypercoagulability in vivo.
    Dupe RJ; Howell RM
    Biochem J; 1973 Jun; 133(2):311-21. PubMed ID: 4723777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The purification and properties of activated factor X. Bovine factor X activated with Russell's viper venom.
    Radcliffe RD; Barton PG
    J Biol Chem; 1972 Dec; 247(23):7735-42. PubMed ID: 4636332
    [No Abstract]   [Full Text] [Related]  

  • 3. The mechanism of activation of bovine factor X (Stuart factor) by intrinsic and extrinsic pathways.
    Fujikawa K; Coan MH; Legaz ME; Davie EW
    Biochemistry; 1974 Dec; 13(26):5290-9. PubMed ID: 4474002
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular characteristics of bovine factor X activated in concentrated sodium citrate solution.
    Radcliffe RD; Barton PG
    Arch Biochem Biophys; 1973 Apr; 155(2):381-90. PubMed ID: 4735850
    [No Abstract]   [Full Text] [Related]  

  • 5. The preparation of activated factor X and its action on prothrombin.
    Jesty J; Esnouf MP
    Biochem J; 1973 Apr; 131(4):791-9. PubMed ID: 4737325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of activation of factor X. Kinetic control of alternative pathways leading to the formation of activated factor X.
    Jesty J; Spencer AK; Nemerson Y
    J Biol Chem; 1974 Sep; 249(17):5614-22. PubMed ID: 4416355
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on bovine factor X. I. Large-sclae purification of the bovine plasma protein possessing factor X activity.
    Jackson CM; Johnson TF; Hanahan DJ
    Biochemistry; 1968 Dec; 7(12):4492-505. PubMed ID: 5700668
    [No Abstract]   [Full Text] [Related]  

  • 8. PURIFICATION AND PROPERTIES OF BOVINE FACTOR X: MOLECULAR CHANGES DURING ACTIVATION.
    PAPAHADJOPOULOS D; YIN ET; HANAHAN DJ
    Biochemistry; 1964 Dec; 3():1931-9. PubMed ID: 14269313
    [No Abstract]   [Full Text] [Related]  

  • 9. A method for the simultaneous isolation of factor X and prothrombin from bovine plasma.
    Esnouf MP; Lloyd PH; Jesty J
    Biochem J; 1973 Apr; 131(4):781-9. PubMed ID: 4737324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of human factor X from factor Xa by reversed-phase high-performance liquid chromatography.
    Shitanishi KT; Herring SW
    J Chromatogr; 1988 Jul; 444():107-13. PubMed ID: 3204125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some characteristics of the Coagulation Factor Xa purified from human serum.
    Berre AG; Osterud B; Christensen TB; Holm T; Prydz H
    Biochem J; 1973 Dec; 135(4):791-5. PubMed ID: 4778275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of blood coagulation factors II, VII, IX and X from bovine citrated plasma.
    Reekers P; Hemker HC
    Haemostasis; 1972; 1(1):2-22. PubMed ID: 4668761
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential interaction of clotting factors II, VII, IX and X with sephadex and dextran blue.
    Swart AC; Kop-Klaassen BH; Hemker HC
    Haemostasis; 1972-1973; 1(5):237-52. PubMed ID: 4670119
    [No Abstract]   [Full Text] [Related]  

  • 14. Scanning electron microscopic and electrophoretic observations on barium sulphate used to absorb clotting factors.
    Howell RM; Deacon SL
    Thromb Diath Haemorrh; 1975 Apr; 33(2):256-70. PubMed ID: 237336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of Factor VII from bovine plasma. Reaction with tissue factor and activation of Factor X.
    Jesty J; Nemerson Y
    J Biol Chem; 1974 Jan; 249(2):509-15. PubMed ID: 4809529
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparation of bovine blood coagulation factors X1 and X2.
    Ong TC; Loh KW; Tan PY
    Biol Chem Hoppe Seyler; 1985 Dec; 366(12):1103-8. PubMed ID: 4091970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on factor X activity after adsorption to barium sulphate.
    Howell RM; Dupe RJ
    Thromb Diath Haemorrh; 1972 Oct; 28(2):306-16. PubMed ID: 4639663
    [No Abstract]   [Full Text] [Related]  

  • 18. The localization of a vitamin K-induced modification in an N-terminal fragment of human prothrombin.
    Skotland T; Holm T; Osterud B; Flengsrud R; Prydz H
    Biochem J; 1974 Oct; 143(1):29-37. PubMed ID: 4219283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simplified procedure for purification of human prothrombin, factor IX and factor X.
    Bajaj SP; Rapaport SI; Prodanos C
    Prep Biochem; 1981; 11(4):397-412. PubMed ID: 7312833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactions of activated factor X-phosphatide mixtures in vitro and in vivo.
    Barton PG; Yin ET; Wessler S
    J Lipid Res; 1970 Mar; 11(2):87-95. PubMed ID: 5418483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.